Cost Effectiveness and Functional Outcomes of Smartphone Cardiac Rehabilitation Assisted Self Management SCRAM versus Centre Based Cardiac Rehabilitation among Patients with Coronary Heart Disease in Southern India A Multicentre Randomized Clinical Trial
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
ABSTRACT
newlineBackground: Coronary Heart Disease (CHD) is the major cause of increasing mortality
newlineworldwide, as well as in India. CHD has been successfully managed by medical and cardiac
newlinerevascularization surgeries for the long time. Cardiac Rehabilitation (CR) programs play a
newlinevital role in secondary health care management for post CHD. Benefits from various CR
newlineprograms like centre based CR, home based CR and through telerehabilitation has been
newlineproven all over the world including developing countries like India. But adherence to CR
newlineprograms and cost effectiveness related to that has been studied least in India. Aim of this
newlinestudy: To identify, analyse and compare the cost effectiveness and functional outcomes of
newlineSmartphone Cardiac Rehabilitation Assisted self Management (SCRAM) versus Centre Based
newlineCardiac Rehabilitation (CBCR) among Coronary Heart Disease patients (CHD) in Southern
newlineIndia. Methodology: A multicentre randomized clinical trial has been done through purposive
newlinesampling with 78 participants who fulfilled the selection criteria, and they have been divided
newlineinto 39 each of CBCR and SCRAM groups by block randomization. CBCR group received
newlineexercise programs in hospital or rehabilitation setup, whereas SCRAM group received it
newlinethrough whatsapp video call based telerehabilitation. Baseline, after 24 weeks of intervention,
newline3 months, 6 months and 1 year post intervention follow up outcome measures of 6MWTD,
newlineTalk Test scores in VAS, SF36, cost effectiveness, HDL and HbA1c - 3 months Average were
newlinerecorded for data analysis. Results: There was statistically significant improvement in all
newlineoutcome measures within group post intervention comparison with pand#8804;0.05, whereas between
newlinegroups comparison was not showing significant results. But in follow ups, gained results
newlineduring both interventions of CBCR or SCRAM were not statistically significant. Regarding
newlinecost effectiveness, SCRAM group showed statistically significant reduction in cost without
newlinecompromising functional outcomes and quality of life in CHD p